Foley Hoag LLP and ten of its partners have been recognized in the 2024 edition of Intellectual Asset Management (IAM) magazine’s IAM Patent 1000 guide, which identifies the best-in-class patent prosecution, licensing and litigation practitioners and firms across the globe.

IAM commended Foley Hoag, sharing: “[T]he unique synergy between their patent litigation and patent prosecution groups sets them apart as a favourite one-stop shop for all patent needs, leaving clients confident that they are receiving the best representation across the whole spectrum of services.”

The following Foley Hoag partners were also recognized for excellence in the industry in the following jurisdictions, and were described by IAM as:

Barbara Fiacco (National) and Donald Ware (MA) ranked in the Gold tier for litigation.

“Two of the most high-quality trial lawyers Boston has to offer,” and “A formidable team in life sciences litigation, securing multiple victories for the Dana-Farber Cancer Institute, resulting in significant payouts as well as co-ownership of groundbreaking cancer treatment patents.”

Jeffrey I.D. Lewis (NY) and Peter Sullivan (NY) 

“Lewis offer[s] expertise in pharmaceutical and technology cases, and Sullivan co-chair[s] the firm’s PTAB group. Well placed to handle a range of patent needs, the pair recently teamed up to represent RideShare Displays in an inter partes review proceeding. Providing full support throughout the product and patent lifecycle.”

Susan Abelleira (MA) 

“A dextrous patent counsel, with a niche in helping pharmaceutical, biology and chemical industry players, including Karyopharm Therapeutics, a longstanding client of the outfit that trusts her with due diligence advice relating to its patents.”

Dana Gordon (MA) 

“Understands the science behind the patents, leveraging his chemistry PhD to offer unique insight into the building and managing of his patrons’ IP assets, both in the United States and across the world.”

David Halstead (MA) 

“Adept in life sciences-related patent matters,” and “A calm, steady hand who is very experienced at worldwide patent prosecution. He and his team provide expert analysis and recommendations regarding our portfolio, and interact with local patent firms in a variety of jurisdictions on our behalf.”

John Lanza (MA) 

“Can be looked to for business-centric patent protection and acquisition advice by companies of all sizes.”

DeAnn Smith (MA)

“Offers diversity in her range of expertise, from patent counselling for big-name pharmaceutical companies, to specialised advice regarding IP purchases, to deftly handling proceedings before the PTAB.”

Jeremy Younkin (MA)

“A sound litigator for both patent and trade secret matters. His recent work includes successfully defending Elysium Health against infringement claims, and an ongoing case alongside Fiacco representing Enanta Pharmaceuticals in an infringement case against Pfizer.”

The annual IAM Patent 1000 guide is compiled following an extensive research process conducted over a five month-period. Individuals qualify for a listing when they receive sufficient positive feedback from peers and clients with knowledge of their practice and the market within which they operate. Firms qualify for a listing on the basis of their depth of expertise, market presence and the level of work on which they are typically engaged.